Prowling Teva Could Boost Some Pharma ETFs
March 30, 2015 at 08:00 AM EDT
Teva Pharmaceuticals (NasdaqGS: TEVA), the largest publicly traded Israeli company, could join the already hot healthcare mergers and acquisitions race and that could prove meaningful for some pharmaceuticals exchange traded funds. “Teva has over $10 billion in debt capacity to spend on...